Our results provide a better understanding of hypoxia-induced chemoresistance and the hypoxia/PVT1/miR-140-3p/ATG5/autophagy signaling axis may be a novel treatment target for lung cancer. This evidence concerns the gene ATG5 and lung carcinoma.